HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LeRoy E Rabbani Selected Research

von Willebrand Factor

12/2004Dynamic variability of hemostatic and fibrinolytic factors in young women.
12/2002Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


LeRoy E Rabbani Research Topics

Disease

5Myocardial Infarction
01/2020 - 06/2003
5Chest Pain (Chest Pains)
01/2017 - 06/2003
4Acute Coronary Syndrome
06/2022 - 05/2003
4COVID-19
04/2020 - 01/2020
4Thrombosis (Thrombus)
01/2010 - 12/2002
3Cardiovascular Diseases (Cardiovascular Disease)
06/2022 - 10/2009
3Hypertension (High Blood Pressure)
04/2020 - 01/2002
3Heart Diseases (Heart Disease)
01/2020 - 03/2005
3Hyperplasia
01/2019 - 10/2003
3ST Elevation Myocardial Infarction
09/2012 - 09/2004
2Lung Diseases (Lung Disease)
04/2020 - 01/2020
2Clinical Deterioration
04/2020 - 01/2020
2Critical Illness (Critically Ill)
04/2020 - 01/2020
2Atherosclerosis
09/2015 - 04/2004
2Pathologic Constriction (Stenosis)
04/2015 - 03/2009
2Vascular Diseases (Vascular Disease)
01/2010 - 04/2004
2Coronary Disease (Coronary Heart Disease)
01/2010 - 12/2004
2Inflammation (Inflammations)
06/2005 - 04/2004
1Cardiogenic Shock
01/2022
1Myocarditis (Carditis)
01/2020
1Heart Failure
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1Brain Hypoxia (Cerebral Hypoxia)
04/2010
1Hemorrhage
10/2009
1Hematoma
10/2009
1Neointima
10/2003
1Heart Arrest (Cardiac Arrest)
06/2003
1Stroke (Strokes)
01/2002
1Carotid Artery Diseases
01/2002
1Diabetes Mellitus
01/2002

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
04/2020 - 06/2003
3fibrin fragment D (D-dimer)IBA
04/2020 - 12/2004
3Interleukin-6 (Interleukin 6)IBA
04/2020 - 01/2006
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
09/2012 - 03/2011
2von Willebrand FactorIBA
12/2004 - 12/2002
1omega-Chloroacetophenone (Mace)IBA
06/2022
1Troponin T (Troponin T1)IBA
06/2022
1TroponinIBA
06/2022
1Trinitrotoluene (TNT)IBA
06/2022
1Biological ProductsIBA
01/2019
1cangrelorIBA
01/2017
1LipidsIBA
09/2015
1CalciumIBA
09/2015
1Phenobarbital (Luminal)FDA Link
04/2015
1TicagrelorIBA
09/2012
1Clopidogrel (Plavix)FDA Link
10/2009
1Heparin (Liquaemin)FDA LinkGeneric
10/2009
1bivalirudin (Angiomax)FDA Link
10/2009
1Glycoproteins (Glycoprotein)IBA
10/2009
1MetalsIBA
03/2009
1HomocysteineIBA
01/2006
1Plasminogen InactivatorsIBA
12/2004
1Fibrinogen (Factor I)FDA Link
12/2004
1Hemostatics (Antihemorrhagics)IBA
12/2004
1Estrogens (Estrogen)FDA Link
12/2004
1FibrinIBA
12/2004
1Tissue Plasminogen Activator (Alteplase)FDA Link
12/2004
1Lipoproteins (Lipoprotein)IBA
04/2004
1Complement System Proteins (Complement)IBA
04/2004
1C-Reactive ProteinIBA
04/2004
1Minocycline (Cyclops)FDA LinkGeneric
10/2003
1AntigensIBA
12/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2002
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2002
1LDL CholesterolIBA
01/2002

Therapy/Procedure

5Percutaneous Coronary Intervention
09/2012 - 09/2004
4Stents
11/2015 - 03/2009
3Secondary Prevention
01/2017 - 05/2003
3Therapeutics
01/2017 - 06/2003
3Drug Therapy (Chemotherapy)
09/2012 - 12/2008
2Renal Replacement Therapy (Therapies, Renal Replacement)
04/2020 - 01/2020
2Artificial Respiration (Mechanical Ventilation)
04/2020 - 01/2020
2Catheters
12/2013 - 04/2010
1Heart-Assist Devices
01/2022
1Critical Care (Surgical Intensive Care)
01/2020
1Drug-Eluting Stents
03/2009
1Length of Stay
03/2005
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
06/2003
1Cardiopulmonary Resuscitation (CPR)
06/2003